https://stock.noler.com/us/stock/soleno-therapeutics-inc https://stock.noler.com/us/stock/soleno-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/soleno-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/soleno-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/soleno-therapeutics-inc/accrued-income-taxes https://stock.noler.com/us/stock/soleno-therapeutics-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/soleno-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/soleno-therapeutics-inc/acquisition-consideration-transferred https://stock.noler.com/us/stock/soleno-therapeutics-inc/acquisition-consideration-transferred-equity-interests-issued-and-issuable https://stock.noler.com/us/stock/soleno-therapeutics-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/soleno-therapeutics-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/soleno-therapeutics-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/soleno-therapeutics-inc/acquisitions https://stock.noler.com/us/stock/soleno-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/soleno-therapeutics-inc/adjustment-for-amortization https://stock.noler.com/us/stock/soleno-therapeutics-inc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/soleno-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/soleno-therapeutics-inc/amortization https://stock.noler.com/us/stock/soleno-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/soleno-therapeutics-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/soleno-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/soleno-therapeutics-inc/aoci https://stock.noler.com/us/stock/soleno-therapeutics-inc/area-of-real-estate-property https://stock.noler.com/us/stock/soleno-therapeutics-inc/asset-acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/asset-acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/soleno-therapeutics-inc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/soleno-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/soleno-therapeutics-inc/available-for-sale-debt-allowance-for-credit-loss https://stock.noler.com/us/stock/soleno-therapeutics-inc/available-for-sale-debt-allowance-for-credit-loss-not-previously-recorded https://stock.noler.com/us/stock/soleno-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/soleno-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/soleno-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/soleno-therapeutics-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/soleno-therapeutics-inc/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/soleno-therapeutics-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/soleno-therapeutics-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/soleno-therapeutics-inc/buybacks-stock-repurchased-value https://stock.noler.com/us/stock/soleno-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/soleno-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/soleno-therapeutics-inc/capital-lease-obligations-incurred https://stock.noler.com/us/stock/soleno-therapeutics-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/soleno-therapeutics-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/soleno-therapeutics-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/soleno-therapeutics-inc/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/soleno-therapeutics-inc/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/soleno-therapeutics-inc/capital-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/soleno-therapeutics-inc/capital-units-authorized https://stock.noler.com/us/stock/soleno-therapeutics-inc/cash https://stock.noler.com/us/stock/soleno-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/soleno-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/soleno-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/soleno-therapeutics-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/soleno-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/soleno-therapeutics-inc/cash-provided-by-used-in-financing-activities-discontinued-operations https://stock.noler.com/us/stock/soleno-therapeutics-inc/cash-provided-by-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/soleno-therapeutics-inc/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/soleno-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/soleno-therapeutics-inc/commitments-and-contingencies https://stock.noler.com/us/stock/soleno-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/soleno-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/soleno-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/soleno-therapeutics-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/soleno-therapeutics-inc/contractual-obligation https://stock.noler.com/us/stock/soleno-therapeutics-inc/contractual-obligation-due-after-fifth-year https://stock.noler.com/us/stock/soleno-therapeutics-inc/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/soleno-therapeutics-inc/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/soleno-therapeutics-inc/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/soleno-therapeutics-inc/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/soleno-therapeutics-inc/contractual-obligation-future-minimum-payments-due-remainder-of-fiscal-year https://stock.noler.com/us/stock/soleno-therapeutics-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/soleno-therapeutics-inc/convertible-debt-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/soleno-therapeutics-inc/cost-of-revenue https://stock.noler.com/us/stock/soleno-therapeutics-inc/costs-and-expenses https://stock.noler.com/us/stock/soleno-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/soleno-therapeutics-inc/current-assets https://stock.noler.com/us/stock/soleno-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/soleno-therapeutics-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/soleno-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/soleno-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/soleno-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/soleno-therapeutics-inc/debt-carrying-amount https://stock.noler.com/us/stock/soleno-therapeutics-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/soleno-therapeutics-inc/debt-convertible-threshold-percentage-of-stock-price-trigger https://stock.noler.com/us/stock/soleno-therapeutics-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/soleno-therapeutics-inc/debt-issued https://stock.noler.com/us/stock/soleno-therapeutics-inc/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/soleno-therapeutics-inc/deconsolidation-gain-or-loss-amount https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-costs https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-gross-noncurrent https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-other https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/soleno-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/soleno-therapeutics-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/soleno-therapeutics-inc/depreciation https://stock.noler.com/us/stock/soleno-therapeutics-inc/depreciation-and-amortization-discontinued-operations https://stock.noler.com/us/stock/soleno-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/soleno-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/soleno-therapeutics-inc/dilutive-securities https://stock.noler.com/us/stock/soleno-therapeutics-inc/discontinued-operation-gain-loss-from-disposal-of-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/soleno-therapeutics-inc/discontinued-operation-gain-loss-on-disposal-of-discontinued-operation-net-of-tax https://stock.noler.com/us/stock/soleno-therapeutics-inc/discontinued-operation-gain-loss-on-disposal-of-discontinued-operation-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/soleno-therapeutics-inc/discontinued-operation-income-loss-from-discontinued-operation-during-phase-out-period-net-of-tax https://stock.noler.com/us/stock/soleno-therapeutics-inc/discontinued-operation-income-loss-from-discontinued-operation-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/soleno-therapeutics-inc/discontinued-operation-tax-effect-of-income-loss-from-disposal-of-discontinued-operation https://stock.noler.com/us/stock/soleno-therapeutics-inc/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/soleno-therapeutics-inc/dividends-payable-current-and-noncurrent https://stock.noler.com/us/stock/soleno-therapeutics-inc/due-from-related-parties-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/soleno-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/soleno-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/eps https://stock.noler.com/us/stock/soleno-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/soleno-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/soleno-therapeutics-inc/fair-value-of-assets-acquired https://stock.noler.com/us/stock/soleno-therapeutics-inc/finance-lease-interest-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/soleno-therapeutics-inc/finance-lease-liability https://stock.noler.com/us/stock/soleno-therapeutics-inc/finance-lease-liability-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/soleno-therapeutics-inc/finance-lease-liability-payments-due https://stock.noler.com/us/stock/soleno-therapeutics-inc/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/soleno-therapeutics-inc/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/soleno-therapeutics-inc/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/soleno-therapeutics-inc/finance-lease-principal-payments https://stock.noler.com/us/stock/soleno-therapeutics-inc/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/soleno-therapeutics-inc/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/soleno-therapeutics-inc/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/soleno-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/soleno-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/soleno-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/soleno-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/soleno-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/soleno-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/soleno-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/soleno-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/soleno-therapeutics-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/soleno-therapeutics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/soleno-therapeutics-inc/finite-lived-patents-gross https://stock.noler.com/us/stock/soleno-therapeutics-inc/foreign-pretax-income https://stock.noler.com/us/stock/soleno-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/soleno-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/soleno-therapeutics-inc/gain-loss-on-contract-termination https://stock.noler.com/us/stock/soleno-therapeutics-inc/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/soleno-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/soleno-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/goodwill https://stock.noler.com/us/stock/soleno-therapeutics-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/soleno-therapeutics-inc/gross-profit https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-loss-from https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-tax https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-tax-paid-federal-after-refund-received https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-tax-paid-foreign-after-refund-received https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-tax-paid-foreign-before-refund-received https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-tax-paid-state-and-local-after-refund-received https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/soleno-therapeutics-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-due-from-related-parties https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/soleno-therapeutics-inc/increase-in-restricted-cash https://stock.noler.com/us/stock/soleno-therapeutics-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/soleno-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/soleno-therapeutics-inc/induced-conversion-of-convertible-debt-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/soleno-therapeutics-inc/insider-transactions-corporate-securities/sales https://stock.noler.com/us/stock/soleno-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/soleno-therapeutics-inc/insider-transactions-other/purchases https://stock.noler.com/us/stock/soleno-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/soleno-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/soleno-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/soleno-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/soleno-therapeutics-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/soleno-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/soleno-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/soleno-therapeutics-inc/interest-expense-nonoperating https://stock.noler.com/us/stock/soleno-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/soleno-therapeutics-inc/interest-income-other https://stock.noler.com/us/stock/soleno-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/soleno-therapeutics-inc/interest-payable-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/inventory https://stock.noler.com/us/stock/soleno-therapeutics-inc/inventory-finished-goods https://stock.noler.com/us/stock/soleno-therapeutics-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/soleno-therapeutics-inc/inventory-raw-materials https://stock.noler.com/us/stock/soleno-therapeutics-inc/inventory-raw-materials-and-supplies https://stock.noler.com/us/stock/soleno-therapeutics-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/soleno-therapeutics-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/soleno-therapeutics-inc/inventory-work-in-process https://stock.noler.com/us/stock/soleno-therapeutics-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/soleno-therapeutics-inc/inventory-write-down https://stock.noler.com/us/stock/soleno-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/soleno-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/soleno-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/soleno-therapeutics-inc/lease-cost https://stock.noler.com/us/stock/soleno-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/soleno-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/soleno-therapeutics-inc/liabilities-noncurrent https://stock.noler.com/us/stock/soleno-therapeutics-inc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/liabilities-of-disposal-group-including-discontinued-operation-noncurrent https://stock.noler.com/us/stock/soleno-therapeutics-inc/line-of-credit https://stock.noler.com/us/stock/soleno-therapeutics-inc/line-of-credit-facility-interest-rate https://stock.noler.com/us/stock/soleno-therapeutics-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/soleno-therapeutics-inc/line-of-credit-facility-periodic-payment-interest https://stock.noler.com/us/stock/soleno-therapeutics-inc/lines-of-credit-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/long-term-debt https://stock.noler.com/us/stock/soleno-therapeutics-inc/long-term-debt-percentage-bearing-fixed-interest-rate https://stock.noler.com/us/stock/soleno-therapeutics-inc/long-term-investments https://stock.noler.com/us/stock/soleno-therapeutics-inc/long-term-purchase-commitment-amount https://stock.noler.com/us/stock/soleno-therapeutics-inc/marketable-securities https://stock.noler.com/us/stock/soleno-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/marketable-securities-noncurrent https://stock.noler.com/us/stock/soleno-therapeutics-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/soleno-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/soleno-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/soleno-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/soleno-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/soleno-therapeutics-inc/net-income https://stock.noler.com/us/stock/soleno-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/soleno-therapeutics-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/soleno-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/soleno-therapeutics-inc/number-of-reportable-segments https://stock.noler.com/us/stock/soleno-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/soleno-therapeutics-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/soleno-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-income https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-leases-rent-expense-sublease-rentals https://stock.noler.com/us/stock/soleno-therapeutics-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-commitment https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-commitment-due-after-fifth-year https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-commitment-due-in-fourth-year https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-commitment-due-in-next-twelve-months https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-commitment-due-in-second-year https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-commitment-due-in-third-year https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-commitments-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-income https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-intangible-assets-net https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-noncash-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-noncash-income-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-nonrecurring-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-nonrecurring-income-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-operating-activities-cash-flow-statement https://stock.noler.com/us/stock/soleno-therapeutics-inc/other-sundry-liabilities-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/soleno-therapeutics-inc/paid-in-capital-income-tax-deficiency-from-share-based-compensation https://stock.noler.com/us/stock/soleno-therapeutics-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/soleno-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/soleno-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/soleno-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/soleno-therapeutics-inc/payments-for-repurchase-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/soleno-therapeutics-inc/payments-for-royalties https://stock.noler.com/us/stock/soleno-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/soleno-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/soleno-therapeutics-inc/payments-to-acquire-assets-investing-activities https://stock.noler.com/us/stock/soleno-therapeutics-inc/payments-to-acquire-businesses-and-interest-in-affiliates https://stock.noler.com/us/stock/soleno-therapeutics-inc/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/soleno-therapeutics-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/soleno-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/soleno-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/soleno-therapeutics-inc/preferred-stock-conversions-inducements https://stock.noler.com/us/stock/soleno-therapeutics-inc/preferred-stock-dividends-and-other-adjustments https://stock.noler.com/us/stock/soleno-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/soleno-therapeutics-inc/preferred-stock-redemption-discount https://stock.noler.com/us/stock/soleno-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/soleno-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/soleno-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/soleno-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/soleno-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/soleno-therapeutics-inc/pretax-income-domestic https://stock.noler.com/us/stock/soleno-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/soleno-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/soleno-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/soleno-therapeutics-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/soleno-therapeutics-inc/proceeds-from-issuance-of-preferred-stock-preference-stock-and-warrants https://stock.noler.com/us/stock/soleno-therapeutics-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/soleno-therapeutics-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/soleno-therapeutics-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/soleno-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/soleno-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/soleno-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/soleno-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/soleno-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/soleno-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/soleno-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/soleno-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/soleno-therapeutics-inc/public-float https://stock.noler.com/us/stock/soleno-therapeutics-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/soleno-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/soleno-therapeutics-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/soleno-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/soleno-therapeutics-inc/revenue https://stock.noler.com/us/stock/soleno-therapeutics-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/soleno-therapeutics-inc/revenue-from-grants https://stock.noler.com/us/stock/soleno-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/soleno-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/soleno-therapeutics-inc/royalty-guarantees-commitments-amount https://stock.noler.com/us/stock/soleno-therapeutics-inc/sale-leaseback-transaction-current-period-gain-recognized https://stock.noler.com/us/stock/soleno-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/soleno-therapeutics-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/soleno-therapeutics-inc/sales-revenue-net https://stock.noler.com/us/stock/soleno-therapeutics-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/share-price https://stock.noler.com/us/stock/soleno-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/soleno-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/soleno-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/soleno-therapeutics-inc/shares-issued-for-acquisitions https://stock.noler.com/us/stock/soleno-therapeutics-inc/shares-issued-shares-purchase-of-assets https://stock.noler.com/us/stock/soleno-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/soleno-therapeutics-inc/short-term-lease-cost https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-award-fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-award-percentage-of-outstanding-stock-maximum https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-award-shares-issued-in-period https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/soleno-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/soleno-therapeutics-inc/sublease-income https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-rate-reconciliation-cross-border-tax-effect-amount https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-rate-reconciliation-cross-border-tax-effect-percent https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-reconciliation-disposition-of-business https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-reconciliation-tax-contingencies https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/soleno-therapeutics-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/soleno-therapeutics-inc/temporary-equity-aggregate-amount-of-redemption-requirement https://stock.noler.com/us/stock/soleno-therapeutics-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/soleno-therapeutics-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/soleno-therapeutics-inc/total-assets https://stock.noler.com/us/stock/soleno-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/soleno-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/soleno-therapeutics-inc/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/soleno-therapeutics-inc/undistributed-earnings-loss-allocated-to-participating-securities-diluted https://stock.noler.com/us/stock/soleno-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/soleno-therapeutics-inc/utb-decrease-from-current-year-positions https://stock.noler.com/us/stock/soleno-therapeutics-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/soleno-therapeutics-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/soleno-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/soleno-therapeutics-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/soleno-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/soleno-therapeutics-inc/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/soleno-therapeutics-inc/valuation-allowances-and-reserves-charged-to-cost-and-expense https://stock.noler.com/us/stock/soleno-therapeutics-inc/valuation-allowances-and-reserves-deductions https://stock.noler.com/us/stock/soleno-therapeutics-inc/variable-lease-cost https://stock.noler.com/us/stock/soleno-therapeutics-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/soleno-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted